Duke University Health System shared a post on LinkedIn:
“Duke Health is expanding access to cell and gene therapies, advancing our commitment to delivering innovative treatments for patients with cancer and other serious diseases.
With expertise spanning CAR T-cell therapy, gene therapy, stem cell transplantation, and emerging cellular therapies, Duke continues to invest in the people, programs, and infrastructure needed to bring cutting-edge care to more patients.
These efforts reflect Duke Health’s commitment to transforming discoveries into life-changing treatments.”
Other posts about Duke University Health System on OncoDaily.
